CORPORATES Granules India subsidiary receives US FDA EIR with NAI status for Virginia facility Mar 5, 2026
CORPORATES Granules India subsidiary receives FDA Tentative Approval for Generic Amphetamine Extended-Release Orally Disintegrating Tablets Dec 22, 2025
CORPORATES Granules India subsidiary receives five procedural observations after US FDA GMP inspection Dec 19, 2025
Granules India says US FDA action may impact new product approvals, expect meet with FDA soon Dec 4, 2024
Granules India stock falls over 10% from day’s high as US FDA classifies inspection as “Official Action Indicated” Dec 3, 2024
Granules India shares surge 2% after US FDA grants ‘No Action Indicated’ status to Andhra Pradesh facility Nov 8, 2024
Granules India’s Andhra Pradesh facility receives ‘No Action Indicated’ status from US FDA Nov 8, 2024